News
Roche’s antibody cocktail lowers hospitalisation by 70% in Covid-19 patients
Roche has reported that the Phase III REGN-COV 2067 trial of investigational antibody cocktail of casirivimab and imdevimab met its primary endpoint of reducing...
Clinical Trials
Phase 3 Trial Shows REGEN-COV antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Regeneron Pharmaceuticals, Inc. announced positive topline results from the largest trial to date assessing a COVID-19 treatment in infected non-hospitalized patients (n=4,567). This definitive...
Clinical Trials
BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging
BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, announced that it has commenced a Phase 2...
News
Plus Therapeutics, Piramal Ink Master Services Agreement
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and difficult to treat cancers, announced that it has entered into...
News
ICPA Health Products Ltd Pledges Support Towards India’s Largest Vaccination Drive
ICPA Health Products Ltd (ICPA), India’s leading pharma company in the oral healthcare segment, as part of its CSR activity has donated a sum...
Clinical Trials
Accenture and Phesi urges pharmaceutical companies to make use of synthetic data in clinical trials
Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, and Accenture, a global services and consulting company with leading capabilities...
News
Glenmark Pharma receives US FDA approval for generic Cardizem SR capsules
Glenmark Pharmaceuticals has received final approval by the United States FDA for diltiazem hydrochloride extended-release capsules USP, 60 mg, 90 mg, and 120 mg....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read